Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Healthcare (NYSE:PBH) will release its fiscal 2026 fourth quarter and year-end earnings on Wednesday, May 13, 2026 after market close.
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE:PBH) will release its fiscal 2026 fourth quarter and year-end earnings on Wednesday, May 13, 2026 after market close.
The company will host a conference call on Thursday, May 14, 2026 at 8:30 a.m. ET, available via live webcast on the Investor Relations page and by phone with prior registration; a replay will be posted for about one week.
Positive
- None.
Negative
- None.
Details
News Market Reaction – PBH
On Apr 30, the day this news came out, PBH closed 0.54% above the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Earnings release date
- May 13, 2026
- Fiscal 2026 Q4 and year-end earnings release after market close
- Conference call time
- 8:30 a.m. ET
- Earnings conference call on May 14, 2026
- Conference call date
- May 14, 2026
- Earnings call to discuss fiscal 2026 Q4 and year-end results
- Replay duration
- approximately one week
- Replay availability following completion of the live earnings call
Historical Context
-
Announced $1.045B Breathe Right and brands acquisition, seen as accretive.
-
Q3 FY2026 revenue and EPS declined year over year with narrowed guidance.
-
Announced Q3 FY2026 earnings release date and conference participation.
-
Q2 FY2026 results ahead of outlook with raised EPS guidance and buybacks.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close. The following morning, May 14, at 8:30 a.m. ET, the Company will host a conference call to discuss the results.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.